Page last updated: 2024-09-03

imatinib mesylate and Peritoneal Carcinomatosis

imatinib mesylate has been researched along with Peritoneal Carcinomatosis in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	36 (50.00)	29.6817
2010's	32 (44.44)	24.3611
2020's	4 (5.56)	2.80

Authors

Authors	Studies
Aploks, K; Da Dong, X; Dong, M; Gu, KW; Miller, K; Murdande, S; Rahimi-Ardabily, A; Zhang, B	1
Aoki, T; Imoto, H; Kamei, T; Karasawa, H; Kohyama, A; Motoi, F; Musha, H; Naitoh, T; Ohnuma, S; Ono, T; Suzuki, H; Tanaka, N; Unno, M; Watanabe, K; Yamamura, A	1
Awale, L; Deo, KB; Gautam, S; Pandit, N; Pradhan, A; Yadav, TN	1
Dong, F; Lu, LJ; Min, J; Xu, XP	1
Kouyama, M; Nakamitsu, A; Sasaki, M; Shimbara, K; Sugiyama, Y; Takahashi, S; Tazaki, T	1
Agud Fernández, M; Díaz Pedroche, C; Gómez-Martín, C; López López, F	1
Akabori, H; Iida, H; Kaida, S; Kitamura, N; Miyake, T; Mori, T; Shimizu, T; Sonoda, H; Takebayashi, K; Tani, M; Terada, Y; Ueki, T; Yamaguchi, T	1
Chen, YB; Feng, XY; Guo, J; Liu, XC; Ma, MZ; Qiu, HB; Sun, XW; Zhou, ZG; Zhou, ZW	1
Gao, Y; Jing, X; Liu, B; Meng, X; Yu, J	1
Li, WH; Li, WW; Wei, SC; Xu, L	1
Chen, MF; Chiang, KC; Fu, CJ; Jan, YY; Yeh, CN; Yen, TC	1
An, HJ; Kang, YK; Kim, BS; Kim, KH; Oh, ST; Ryoo, BY; Ryu, MH; Sohn, BS; Yook, JH; Yu, CS	1
Dourthe, LM; Heymann, S; Imperiale, A; Sauer, B; Schlund-Schoettel, E	1
Akahoshi, S; Inoue, K; Kiyota, Y; Kiyozumi, Y; Motooka, Y; Yamaguchi, R; Yoshida, Y	1
Bauer, S; Casali, PG; Cats, A; Fiore, M; Fumagalli, E; Gronchi, A; Hohenberger, P; Hoiczyk, M; Kerst, M; Miceli, R; Nguyen, BP; Nyckowski, P; Rutkowski, P; Siedlecki, JA; Treckmann, J; van Coevorden, F	1
Cerullo, C; Fonte, C; Iori, A; Lunghi, A; Molinara, E; Neri, B; Pellegrini, E; Rediti, M	1
Kanehara, I; Kitayama, K; Nishino, H; Nomura, S; Teraoka, H; Toyokawa, T	1
Kirii, Y; Misawa, S; Ota, H; Sakamoto, H; Takagi, H; Takeda, M	1
Francine, AT; Raherinantenaina, F; Rambel, AH; Rantomalala, HY; Rasoaherinomenjanahary, F; Ratsimba, HN; Samison, LH	1
Hosaka, S; Kawamoto, S; Kikutake, T; Nagao, S; Umemoto, S; Yonemitsu, K; Yoshida, T	1
Chong, H; Hagi, T; Ichikawa, Y; Ishikawa, S; Kanazawa, A; Lee, K; Maeda, T; Maruyama, K; Nishihara, M; Oka, H; Shimada, M; Takayama, S; Taniura, N; Ueno, G	1
Fujita, J; Hirota, S; Imamura, H; Kishi, K; Nishida, T; Sato, S; Takagi, M; Takahashi, T; Tsujinaka, T; Yamamoto, K	1
Ding, Y; Wen, G; Xu, L; Zhao, L	1
Komatsu, T; Nomura, S; Ogasawara, T; Shida, T; Takahara, Y; Takahashi, M; Uno, H	1
Basile, F; Brancato, G; Donati, M	1
Fujiwara, Y; Fukuda, S; Inoue, M; Kitani, K; Ohta, Y; Tsujie, M; Wakasa, T; Yukawa, M	1
Klein-Szanto, AJ; Lee, RB; Miner, Z; Schilder, RJ; Senterman, MK; Shaw, TJ; Sill, MW; Vanderhyden, BC	1
Baldridge, LA; Breen, T; Emerson, RE; Johnson, CS; Matei, D; McClean, J; Menning, N; Schilder, J; Stephens, D; Sutton, G; Whalen, C	1
Albiter, M; Bonvalot, S; Dromain, C; Le Cesne, A; Le Péchoux, C; Mabille, M; Shapeero, LG; Terrier, P; Vanel, D	1
Aghajanian, C; Hensley, ML; Iasonos, A; Juretzka, M; Konner, J; Leitao, M; Park, K; Sabbatini, P; Soslow, R; Tew, W	1
Cheng, H; Geist, DE; Piperdi, B; Piperdi, M; Virk, R	1
Kiesel, H; Müller, AM; Schmitt-Graeff, A; Veelken, H	1
Akyurek, N; Benekli, M; Buyukberber, S; Coskun, U; Demirci, U; Karakan, T; Tonyali, O; Yildiz, R	1
Anagnostou, E; Christopoulos, C; Dedemadi, G; Emile, JF; Georgoulis, G; Kontopanos, D; Morphopoulos, G	1
Akiyoshi, T; Fujimoto, Y; Hatake, K; Katori, M; Kuroyanagi, H; Muto, T; Oya, M; Takahashi, S; Ueno, M; Yamaguchi, T; Yamamoto, N	1
Bauer, S; Grabellus, F; Schmid, KW; Sheu, SY; Speich, N; Worm, K	1
Berger, F; Bruns, C; Reichardt, P; Schinwald, N; Schlemmer, M	1
Al-Haddabi, IH; Al-Qadhi, H; Chopra, PJ; Machado, NO	1
Branham, D; Broaddus, RR; Coleman, RL; Gershenson, DM; Levenback, CF; Noguera, IR; Ramirez, PT; Sood, AK; Sun, CC	1
Alaggio, R; Bisogno, G; Cecchetto, G; Cheng, L; d'Amore, ES; Dall'Igna, P; Martignoni, G; Sperlì, D	1
Kinugasa, E; Misawa, S; Ogata, H; Shimada, A; Wada, Y	1
Chikatani, K; Goto, H; Kakimoto, M; Kawashima, H; Kikuchi, A; Koshiishi, H; Liu, B; Miyamoto, H; Nishida, K; Okamura, T; Yoshimura, T	1
Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Minato, H; Morioka, E; Nakano, Y; Nakata, S; Noguchi, M; Ohnishi, T; Ohno, Y; Omote, K; Takamura, H; Tomita, Y; Ueda, N	1
Fujimoto, H; Hirota, S; Kitamura, Y; Ko, S; Miyagawa, S	1
Hasuike, Y; Kawahara, K; Kurata, A; Mishima, H; Mukaide, H; Nishisyou, I; Shin, E; Takeda, Y; Tujinaka, T	1
Antonescu, C; Brennan, MF; Dematteo, RP; Maki, RG	1
Hatakeyama, K; Kanda, T; Kaneko, K; Makino, S; Matsuki, A; Nakagawa, S; Ohashi, M	1
Kondo, H; Motohara, T; Ohira, N; Oku, T; Shikishima, H; Sumiyoshi, T; Takayama, T; Waga, E; Yoshizaki, N	1
Arakawa, Y; Fuchigami, M; Ito, T; Kobayashi, S; Koide, H; Murata, A; Nishiyama, R; Sagawa, C; Takekawa, Y	1
Hasuike, Y; Hirota, S; Ikenaga, M; Kashiwazaki, M; Mano, M; Mishima, H; Miyake, M; Takada, Y; Takeda, Y; Tsujinaka, T	1
Aoki, R; Imoto, Y; Ito, S; Muguruma, N; Nakamoto, J; Okamoto, K; Okamura, S; Okitsu, H; Sano, T; Sato, Y	1
Ando, Y; Beck, Y; Tahara, H; Takayama, T; Tsunoda, T	1
Akisik, FM; Henley, JD; Rajesh, A; Rushing, DA; Rydberg, J; Sandrasegaran, K	1
Jin, ML; Shen, L	1
Albiter, M; Bonvalot, S; Caillet, H; Dromain, C; Le Cesne, A; Le Pechoux, C; Petrow, P; Shapeero, L; Terrier, P; Vanel, D	1
Ausania, F; Caricato, M; Coppola, R; Rabitti, C; Tonini, G; Valeri, S	1
Bodurka, DC; Broaddus, RR; Burke, TW; Coleman, RL; Gershenson, DM; Kavanagh, JJ; Levenback, CF; Wolf, JK	1
Ide, H; Ito, T; Iwase, K; Kainuma, S; Michiura, T; Mikata, S; Mizushima, T; Nonaka, K; Yamanaka, H	1
Iwazawa, T; Katsushima, S; Matsui, S; Monden, T; Nakano, Y; Ohnishi, T; Okamoto, S; Takemoto, H; Tono, T; Yano, H	1
Bonvalot, S; Cavalcanti, A; Cesne, AL; Eldweny, H; Lassau, N; Péchoux, CL; Robert, C; Terrier, P; Vanel, D	1
Al-Kindy, S; Al-Moundhri, MS; Al-Thahli, K; Rao, L; Salam, J	1
Beckers, MM; Slee, PH	1
Fujikawa, K; Hirahara, N; Motojima, R; Motojima, T; Saitoh, T; Sakurai, S; Sano, T; Segawa, A; Todoroki, T; Tsushima, Y; Yamada, S	1
Blasco, SB; Calvet, JD; Carbajo-Ferré, EM; Déjardin, Ddel C; González, MH; Lanao, MA; Lara, CD; Marín, AS; Moreno, VV; Pereferrer, FS; Pérez, JS	1
Boo, YJ; Chae, YS; Jung, CW; Kim, CS; Kim, JH; Kim, SD; Kim, SJ; Mok, YJ; Park, SS	1
Chen, LR	1
Cao, L; Emerson, RE; Jeng, MH; Kelich, S; Matei, D; Menning, N; Rao, J; Sledge, GW	1
Hagiwara, A; Kumano, T; Mizuta, Y; Otsuji, E; Sagara, Y; Sakakura, C; Yamaoka, N	1
Ezumi, K; Ikeda, M; Monden, M; Nomura, M; Sekimoto, M; Takemasa, I; Yamamoto, H	1
Ahmed, MY; Almaroof, B; Castillo-Sang, M; Gociman, B; Mancho, S; Tsang, AW	1
Dryjski, J; Guérin, E; Lefebvre, JC; Mefire, Y; Ouazzani, A; Vaneukem, P	1
Huguier, M	1

Reviews

9 review(s) available for imatinib mesylate and Peritoneal Carcinomatosis

Article	Year
Liver resection for metastatic GIST tumor improves survival in the era of tyrosine kinase inhibitors: a systematic review and meta-analysis. Langenbeck's archives of surgery, 2023, Sep-23, Volume: 408, Issue:1 Topics: Antineoplastic Agents; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver; Peritoneal Neoplasms; Retrospective Studies; Tyrosine Kinase Inhibitors	2023
Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review. World journal of surgical oncology, 2014, May-21, Volume: 12 Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Prognosis; Pyrimidines; Rupture, Spontaneous; Tomography, X-Ray Computed	2014
A lethal mesenteric gastrointestinal stromal tumor: a case report and review of the literature. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:9 Topics: Antineoplastic Agents; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Mesentery; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms	2015
Extragastrointestinal stromal tumors of the omentum: review apropos of a case with a novel gain-of-function KIT mutation. Journal of gastrointestinal cancer, 2009, Volume: 40, Issue:3-4 Topics: Aged; Antineoplastic Agents; Base Sequence; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidental Findings; Male; Molecular Sequence Data; Mutation; Neoplasm Recurrence, Local; Omentum; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines	2009
Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome. JOP : Journal of the pancreas, 2011, Mar-09, Volume: 12, Issue:2 Topics: Acute Disease; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Duodenal Neoplasms; Fatal Outcome; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines	2011
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature. Journal of pediatric surgery, 2012, Volume: 47, Issue:6 Topics: Abdominal Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Child, Preschool; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Imatinib Mesylate; Intestinal Obstruction; Ligaments; Liver Neoplasms; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Perivascular Epithelioid Cell Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Radiography; Sarcoma, Clear Cell; Sirolimus; X Chromosome Inactivation	2012
Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor. Current problems in surgery, 2003, Volume: 40, Issue:3 Topics: Benzamides; Biopsy, Needle; Chemotherapy, Cancer, Regional Perfusion; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Stromal Cells; Survival Analysis; Treatment Outcome	2003
Primary omental gastrointestinal stromal tumor (GIST). World journal of surgical oncology, 2007, Jun-12, Volume: 5 Topics: Aged; Angiography; Benzamides; Biopsy, Needle; Chemotherapy, Adjuvant; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Laparotomy; Male; Omentum; Peritoneal Neoplasms; Piperazines; Pyrimidines; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler	2007
[KIT mutation analysis in pathological diagnosis and target-therapy of gastrointestinal stromal tumors: an update]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:7 Topics: Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Neurofibromatosis 1; Omentum; Peritoneal Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines	2007

Trials

6 trial(s) available for imatinib mesylate and Peritoneal Carcinomatosis

Article	Year
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jul-10, Volume: 26, Issue:20 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Biomarkers, Tumor; Disease-Free Survival; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Probability; Pyrimidines; Risk Assessment; Survival Analysis; Treatment Outcome	2008
Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial. Cancer, 2008, Aug-15, Volume: 113, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Middle Aged; Oncogene Protein v-akt; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Recurrence; Survival Analysis; Taxoids; Treatment Outcome	2008
Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!). European journal of radiology, 2009, Volume: 69, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2009
A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission. European journal of gynaecological oncology, 2008, Volume: 29, Issue:6 Topics: Administration, Oral; Adult; Aged; Benzamides; Disease-Free Survival; Fallopian Tube Neoplasms; Female; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2008
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube. Gynecologic oncology, 2012, Volume: 125, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Taxoids	2012
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecologic oncology, 2006, Volume: 101, Issue:1 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Piperazines; Pyrimidines; Taxoids	2006

Other Studies

57 other study(ies) available for imatinib mesylate and Peritoneal Carcinomatosis

Article	Year
[A Case of Peritoneal Metastasis Resection from GIST of the Small Intestine with Focal Resistance Against Imatinib Mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Male; Peritoneal Neoplasms; Proto-Oncogene Proteins c-kit	2019
Cystic Ileal Gastrointestinal Stromal Tumor Masquerading as Metastatic Adnexal Carcinoma. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:3 Topics: Abdominal Cavity; Aged; Carcinoma; Chemotherapy, Adjuvant; Cysts; Diagnosis, Differential; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Ileum; Imatinib Mesylate; Laparoscopy; Ovarian Neoplasms; Pelvis; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2020
Diffuse primary extra-gastrointestinal stromal tumor of the peritoneum: A rare case report. Medicine, 2020, Oct-02, Volume: 99, Issue:40 Topics: Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Peritoneal Neoplasms	2020
Solitary peritoneal metastasis of gastrointestinal stromal tumor: A case report. World journal of gastroenterology, 2020, Sep-28, Volume: 26, Issue:36 Topics: Aged; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Peritoneum	2020
Concurrent inflammatory bowel disease and gastrointestinal stromal tumor. Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:5 Topics: Aged, 80 and over; Combined Modality Therapy; Crohn Disease; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Immunosuppressive Agents; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Sunitinib	2018
[A Case of Small Intestinal GIST with Long-Term Survival after Tumor Resection for Repeated Peritoneal Recurrence]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Intestine, Small; Peritoneal Neoplasms; Recurrence; Time Factors	2017
Advanced gastrointestinal stromal tumor patients benefit from palliative surgery after tyrosine kinase inhibitors therapy. Medicine, 2018, Volume: 97, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Palliative Care; Peritoneal Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Retrospective Studies; Treatment Outcome	2018
A 4-month-old boy with gastrointestinal stromal tumor of mesocolon. Cancer biology & therapy, 2019, Volume: 20, Issue:1 Topics: Chemotherapy, Adjuvant; Fatal Outcome; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Infant; Male; Mesocolon; Peritoneal Neoplasms; Tomography, X-Ray Computed	2019
Malignant jejunal gastrointestinal stromal tumor with history of prostate cancer: A case report. Medicine, 2019, Volume: 98, Issue:18 Topics: Aged; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Neoplasm Metastasis; Peritoneal Neoplasms; Postoperative Complications; Prostatic Neoplasms; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome	2019
Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jun-01, Volume: 31, Issue:16 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidental Findings; Liver Neoplasms; Middle Aged; Osteonecrosis; Pain; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Range of Motion, Articular; Tibia	2013
The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST. Annals of surgical oncology, 2013, Volume: 20, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Survival Rate	2013
[A rare case of bone metastasis from gastro-intestinal stromal tumour: place of radiotherapy]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:1 Topics: Antineoplastic Agents; Benzamides; Bone Neoplasms; Femoral Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Humerus; Imatinib Mesylate; Ischium; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Osteolysis; Pain Management; Peritoneal Neoplasms; Piperazines; Pubic Bone; Pyrimidines; Stomach Neoplasms	2014
[A case of imatinib-resistant gastrointestinal stromal tumor treated with low-dose sunitinib]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:13 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Salvage Therapy; Sunitinib	2013
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Confounding Factors, Epidemiologic; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Liver Neoplasms; Male; Metastasectomy; Middle Aged; Patient Selection; Peritoneal Neoplasms; Piperazines; Predictive Value of Tests; Prognosis; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Selection Bias; Treatment Outcome	2014
Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report. Anticancer research, 2014, Volume: 34, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Mesentery; Omentum; Peritoneal Neoplasms; Piperazines; Pyrimidines; Rectal Neoplasms; Urinary Bladder Neoplasms	2014
[A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:3 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms	2014
[Gastrointestinal stromal tumor of the ileum with metastatic relapse developed in the mesentery]. The Pan African medical journal, 2014, Volume: 18 Topics: Adult; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Male; Mesentery; Peritoneal Neoplasms; Piperazines; Pyrimidines	2014
[A case of small intestinal gastrointestinal stromal tumor (GIST) with peritoneal dissemination, treated effectively with molecular target drug after operation]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Molecular Targeted Therapy; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Sunitinib	2014
[A case of extragastrointestinal stromal tumor with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intestinal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2014
Primary surgery as a frontline treatment for synchronous metastatic gastrointestinal stromal tumors: an analysis of the Kinki GIST registry. Surgery today, 2016, Volume: 46, Issue:9 Topics: Aged; Catheter Ablation; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Japan; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Protein Kinase Inhibitors; Registries; Retrospective Studies; Survival Rate; Treatment Outcome	2016
[A Case of Multiple Liver Metastases and Peritoneal Dissemination after Resection of a Gastrointestinal Stromal Tumor of the Stomach Successfully Treated with Imatinib Mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Agents; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms	2015
Giant mesenterial gastrointestinal stromal tumour mimicking a permagna hernia: a wolf in sheep's clothing. ANZ journal of surgery, 2018, Volume: 88, Issue:9 Topics: Aged; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Hernia; Humans; Image-Guided Biopsy; Imatinib Mesylate; Male; Mesentery; Peritoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2018
Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report. Journal of medical case reports, 2017, Feb-07, Volume: 11, Issue:1 Topics: Abdominal Pain; Anorexia; Antineoplastic Agents; Combined Modality Therapy; Cytoreduction Surgical Procedures; Disease Progression; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Laparotomy; Middle Aged; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2017
Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour. The Australasian journal of dermatology, 2009, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Methotrexate; Middle Aged; Peritoneal Neoplasms; Piperazines; Psoriasis; Pyrimidines; Treatment Outcome	2009
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDGFRA mutations. Cancer biology & therapy, 2009, Volume: 8, Issue:4 Topics: Administration, Oral; Antigens, CD34; Benzamides; Hemangiosarcoma; Humans; Imatinib Mesylate; Male; Middle Aged; Mutation; Peritoneal Neoplasms; Piperazines; Platelet Endothelial Cell Adhesion Molecule-1; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sequence Analysis, DNA	2009
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Liver; Liver Failure; Middle Aged; Peritoneal Neoplasms; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib	2010
Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case. Surgery today, 2010, Volume: 40, Issue:3 Topics: Aged; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Neoadjuvant Therapy; Peritoneal Neoplasms; Piperazines; Pyrimidines	2010
A novel primary KIT exon 9 single nucleotide substitution c.1427G>T (p.Ser476Ile) in a gastrointestinal stromal tumor. Virchows Archiv : an international journal of pathology, 2010, Volume: 457, Issue:5 Topics: Adult; Antineoplastic Agents; Base Sequence; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Disease Progression; Exons; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Liver Neoplasms; Male; Molecular Sequence Data; Peritoneal Neoplasms; Piperazines; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sunitinib	2010
Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors. Journal of gastrointestinal cancer, 2012, Volume: 43, Issue:2 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Peritoneal Neoplasms; Piperazines; Positron-Emission Tomography; Pyrimidines	2012
A hemodialysis patient with primary extra-gastrointestinal stromal tumor: favorable outcome with imatinib mesylate. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Ki-67 Antigen; Male; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Renal Dialysis	2012
[A case of extragastric pedunculated gastrointestinal stromal tumor of the stomach with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Peritoneal Neoplasms; Piperazines; Pyrimidines; Stomach Neoplasms	2012
[A case of drug resistant recurrent gastrointestinal stromal tumor treated surgically by resection, partial hepatectomy and diaphragmectomy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Diaphragm; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Jejunal Neoplasms; Liver Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Sunitinib	2012
Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour. The British journal of dermatology, 2002, Volume: 147, Issue:2 Topics: Benzamides; Colonic Neoplasms; Enzyme Inhibitors; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Omentum; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Psoriasis; Pyrimidines; Splenic Neoplasms	2002
[A patient with diffuse peritoneal metastases of GIST who was administered STI571]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12 Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Intestinal Neoplasms; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines	2002
A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor. International journal of clinical oncology, 2003, Volume: 8, Issue:3 Topics: Administration, Oral; Benzamides; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Pyrimidines; Risk Assessment; Stromal Cells; Treatment Outcome	2003
[A case of primary small intestinal gastrointestinal stromal tumor: an intraperitoneal bleeding from greater omentum metastasis caused by administration of imatinib mesylate]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:7 Topics: Aged; Antineoplastic Agents; Benzamides; Gastrointestinal Neoplasms; Hemorrhage; Humans; Imatinib Mesylate; Intestine, Small; Male; Omentum; Peritoneal Diseases; Peritoneal Neoplasms; Piperazines; Pyrimidines; Stromal Cells	2003
[A patient with unresectable gastrointestinal stromal tumor responded to STI571]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:4 Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Radiography, Abdominal; Stomach Neoplasms; Tomography, X-Ray Computed	2004
[A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11 Topics: Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2004
A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination. Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:12 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2004
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case. Surgery today, 2005, Volume: 35, Issue:2 Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2005
Gastrointestinal stromal tumors: CT and MRI findings. European radiology, 2005, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Imatinib Mesylate; Intestine, Small; Liver Neoplasms; Magnetic Resonance Imaging; Male; Mesentery; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Radiographic Image Enhancement; Rectal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed	2005
[Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Edema; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction; Survival Rate	2004
Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients. European journal of radiology, 2005, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Contrast Media; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Iohexol; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Prospective Studies; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome	2005
An omental mass: any hypothesis? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2005, Volume: 7, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Digestive System Surgical Procedures; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Omentum; Peritoneal Neoplasms; Piperazines; Pyrimidines; Splenic Neoplasms; Tomography, X-Ray Computed	2005
[Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13 Topics: Antineoplastic Agents; Benzamides; Drug Administration Schedule; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction	2005
[Gastrointestinal stromal tumor successfully treated with re-administration of STI571 despite of serious skin rash: a case report]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mesentery; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Piperazines; Pyrimidines	2005
Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Annals of surgical oncology, 2006, Volume: 13, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Feasibility Studies; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Liver Neoplasms; Male; Medical Records; Middle Aged; Necrosis; Peritoneal Neoplasms; Piperazines; Preoperative Care; Protein-Tyrosine Kinases; Pyrimidines; Retrospective Studies; Survival Rate	2006
Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis. Saudi medical journal, 2006, Volume: 27, Issue:10 Topics: Antineoplastic Agents; Benzamides; Colitis, Ulcerative; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rectum; Treatment Outcome	2006
Hypercalcaemia in a patient with a gastrointestinal stromal tumour. Clinical endocrinology, 2007, Volume: 66, Issue:1 Topics: Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Gastrointestinal Stromal Tumors; Humans; Hypercalcemia; Imatinib Mesylate; Middle Aged; Pamidronate; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines	2007
Massive intraperitoneal stromal tumour: two-year follow-up. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2007, Volume: 5, Issue:3 Topics: Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2007
Multiple malignant extragastrointestinal stromal tumors of the greater omentum and results of immunohistochemistry and mutation analysis: a case report. World journal of gastroenterology, 2007, Jun-28, Volume: 13, Issue:24 Topics: Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Ki-67 Antigen; Male; Middle Aged; Mutation; Omentum; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha	2007
PDGF BB induces VEGF secretion in ovarian cancer. Cancer biology & therapy, 2007, Volume: 6, Issue:12 Topics: Antineoplastic Agents; Ascitic Fluid; Becaplermin; Benzamides; Cell Line, Tumor; Cystadenoma, Papillary; Female; Humans; Imatinib Mesylate; Neoplasm Proteins; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Phosphatidylinositol 3-Kinases; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Recombinant Fusion Proteins; Signal Transduction; Vascular Endothelial Growth Factor A	2007
[Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Adult; Benzamides; Drug Resistance, Neoplasm; Duodenal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed	2007
Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case. Japanese journal of clinical oncology, 2008, Volume: 38, Issue:3 Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Dacarbazine; Doxorubicin; Fibromatosis, Aggressive; Humans; Imatinib Mesylate; Male; Mesentery; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction; Tamoxifen	2008
A malignant omental extra-gastrointestinal stromal tumor on a young man: a case report and review of the literature. World journal of surgical oncology, 2008, May-15, Volume: 6 Topics: Adult; Antigens, CD34; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Omentum; Peritoneal Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines	2008
Electronic clinical challenges and images in GI. Cystic GIST of the lesser omentum. Gastroenterology, 2008, Volume: 134, Issue:7 Topics: Antineoplastic Agents; Benzamides; Biopsy, Needle; Chemotherapy, Adjuvant; Cysts; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Laparoscopy; Middle Aged; Omentum; Peritoneal Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome	2008
[Effect of a tyrosine kinase inhibitors in a patient with a metastatic gastrointestinal stromal tumor]. Annales de chirurgie, 2001, Volume: 126, Issue:9 Topics: Benzamides; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Middle Aged; Neoplasms, Connective Tissue; Peritoneal Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stomach Neoplasms; Stromal Cells	2001